InsiderTrades

Form 4 for REPL Replimune Group, Inc.

Accepted 2021-07-19 00:00:00 ET · period of report 2021-07-15 · accession 0001104659-21-093671 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-07-19 2021-07-15 REPL Esposito Pamela Chief Business Off M - OptEx $1.01 +4,600 214.8K +2% +$4,646
D 2021-07-19 2021-07-15 REPL Esposito Pamela Chief Business Off S - Sale+OE $33.37 -4,600 210.2K -2% -$153.5K
D 2021-07-19 2021-07-15 REPL Esposito Pamela Chief Business Off M - OptEx $0.00 -4,600 68.6K -6% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-07-15 M A 4,600 $1.01 214,759 D — —
2 Common Common Stock 2021-07-15 S D 4,600 $33.37 210,159 D — — (F2) Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 544,267 shares of the Issuer's common stock, 345,191 of which are exercisable as of the date hereof.
3 Derivative Employee Stock Option (right to buy) 2021-07-15 M D 4,600 $0.00 68,603 D $1.01 · — to 2025-11-01 4,600 Common Stock (F3) The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof.